| Application no. and date | 16871823.7 (espacenet) (Federated) (European Patent Register), 20161209 | | Patent/reg. no. and date | DK/EP 3383371, 20240501 | | Publication date | 20181010 | | Priority no. and date | AU 2015905089, 20151209, US 201662329166 P, 20160428 | | EP pub. no. and date |
EP 3383371 20181010 | | Effective date | | | Applicant/owner | Avecho Biotechnology Limited, Unit A8
2A Westall Road
Clayton, VIC 3168, AU | | Applicant ref. no. | | | Inventor | EL-TAMIMY, Mahmoud, 11 Duerdin Street
Clayton, Victoria 3168, AU | | Representative | | | Opponent | | | IPC Class | A61K 31/05 (2006.01) , A61K 31/355 (2006.01) , A61K 47/10 (2017.01) , A61K 47/22 (2006.01) , A61K 47/26 (2006.01) , A61K 9/107 (2006.01) , A61P 23/00 (2006.01) , A61P 25/20 (2006.01) | | Title | PHARMACEUTICAL FORMULATION | | Int. application no. | AU2016051209 | | Int. publication no. | WO2017096427 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
